Neurocrine Biosciences, Inc. (NBIX)

Neurocrine Biosciences Income Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Revenue	2,413	2,355	1,887	1,489	1,134	1,046
Revenue Growth (YoY)	21.73%	24.81%	26.76%	31.34%	8.38%	32.71%
Cost of Revenue	870.6	765.1	604.7	487	342.4	285.1
Gross Profit	1,542	1,590	1,282	1,002	791.1	760.8
Selling, General & Admin	1,041	1,007	887.6	752.7	583.3	433.3
Operating Expenses	1,041	1,007	887.6	752.7	583.3	433.3
Operating Income	501.4	583	394.8	249	207.8	327.5
Interest Expense	-	-	-	-	-25.8	-32.8
Interest & Investment Income	90.4	91	52.8	4.1	3.8	12.6
EBT Excluding Unusual Items	591.8	674	447.6	253.1	185.8	307.3
Gain (Loss) on Sale of Investments	-69.3	-37.1	28.4	30.8	20.9	-17.7
Other Unusual Items	-49.7	-138.4	-	-70	-	-18.4
Pretax Income	466.2	486	332.1	213.9	101.4	106.7
Income Tax Expense	160.4	144.7	82.4	59.4	11.8	-300.6
Net Income	305.8	341.3	249.7	154.5	89.6	407.3
Net Income to Common	305.8	341.3	249.7	154.5	89.6	407.3
Net Income Growth	-17.28%	36.68%	61.62%	72.43%	-78.00%	1000.81%
Shares Outstanding (Basic)	100	100	98	96	95	93
Shares Outstanding (Diluted)	103	104	101	99	98	98
Shares Change (YoY)	0.78%	2.67%	2.12%	1.02%	0.10%	2.19%
EPS (Basic)	3.05	3.40	2.56	1.61	0.95	4.37
EPS (Diluted)	2.96	3.29	2.47	1.56	0.92	4.16
EPS Growth	-17.91%	33.20%	58.33%	69.56%	-77.89%	966.67%
Free Cash Flow	492.2	557.2	361.6	322.9	233.1	217.6
Free Cash Flow Per Share	4.76	5.37	3.58	3.27	2.38	2.23
Gross Margin	63.91%	67.52%	67.96%	67.29%	69.79%	72.74%
Operating Margin	20.78%	24.75%	20.92%	16.73%	18.33%	31.31%
Profit Margin	12.68%	14.49%	13.23%	10.38%	7.90%	38.94%
Free Cash Flow Margin	20.40%	23.66%	19.16%	21.69%	20.57%	20.80%
EBITDA	529.9	610.1	416.1	264.6	218.7	336.1
EBITDA Margin	21.96%	25.90%	22.05%	17.77%	19.29%	32.14%
D&A For EBITDA	28.5	27.1	21.3	15.6	10.9	8.6
EBIT	501.4	583	394.8	249	207.8	327.5
EBIT Margin	20.78%	24.75%	20.92%	16.73%	18.33%	31.31%
Effective Tax Rate	34.41%	29.77%	24.81%	27.77%	11.64%	-
Revenue as Reported	2,413	2,355	1,887	1,489	1,134	1,046
Advertising Expenses	-	191	159.9	149.7	139.8	64.8

Updated May 5, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q